varian medic system inc engag
manufactur medic devic
softwar treat cancer
medic condit oper
oncolog system varian particl
segment design manufactur sell
servic hardwar softwar product
treat cancer convent radiat
therapi advanc treatment
proton therapi form extern beam
radiotherapi use proton beam
treatment cancer compani
found william hansen edward ginzton
russel varian sigurd varian
headquart palo alto ca
innov varian posit futur increas pt
flash therapi varian medic disclos initi preclin result research
ultra-high dose cancer treatment util proton via public present
american associ cancer research meet atlanta georgia
treatment known flash therapi non-invas therapi cancer deliv
high dose radiat less one second could repres signific
paradigm shift treatment cancer ultim proven safe effect
result varian report preclin result present show
reduc toxic healthi tissu organ compani flash therapi
conduct clinic devic capabl translat human test versu
tradit proton treatment flash treatment show less damag lung
tissu averag reduct skin dermat versu convent method
flash outlook still extrem earli flash therapi seem hold promis
amazingli quick treatment throughput attack cancer tumor larg
spare healthi tissu varian manag state januari human trial flash
therapi could begin within month excit could potenti
revolution cancer treatment clinic patient comfort/satisfact
perspect worth note varian work consortium cancer
center flash initi
busi momentum excel order momentum varian past sever
month extrem strong varian report result three
week obvious result quarter end septemb
show increas oncolog gross order constant currenc basi
most-rec report quarter even stronger repres
decade-high increas gross order constant currenc
commit innov flashforward consortium research varian
conduct potenti quit ground-break initi one
sever way varian tri innov within cancer treatment space
exampl compani current develop multimod adapt radiotherapi
suit driven artifici intellig project hold promis
enhanc clinic decision-mak actual deliveri patient radiat
therapi ai product offer could commerci launch short
think var leadership fulli understand compani must remain forefront
innov order remain market leader space
recommend continu rate share outperform increas
price target previous arriv price target
attach multipl adjust ebitda estim price target
assum approxim million net cash month
pleas see end report begin page import disclosur
revenu
interest incom net
 revenu
sg revenu
pre-shar repo chg wc
million except per share data
ex pe te tp rfo rm th rk th xt nt hs
 im ro co fu ta ls
 nd rv lu cu rr nt
ex pe te rfo rm ou ne th th rk ov th ex mo th
lo -te rm te tia ts ne -te rm ca ta yst
fa irl lu cu rr nt
ex pe te rp rfo rm th ar ke ne th
fu al r- va ue cu le
 el ri ta et fo thi co se /e itd th
ri ks th ou ta rg ric il ie lu mi te fai ur
th om ou rn stim te
th fo st ra tin fo co ni co ar ri gto es rch ia te
 se te mp es th ov ra th mb co ni ra te
 et pr se te co ie th co ag
co th ra li st ls ec er ba rr se rc
ci te ro id stm nk ng rv ic es thi th la th
 th co ie th tp er ra ti th co ie
th ad ar pe fo ra ti
na ly tif ic ion th ea ch yst sp si le fo th ra tio th se rc rt ch pe tu sk fa rti fi
th ie th pa se ur iti xp se th cc ra te ly fl ct rs al io th yst ls
ce ti fi es th rt co sa tio ctl ir ec tli ate th ci fic co da ti ie co ta th rt
 se rc ly st lu tho nv lv th pa ti th po ce co ns tio ti th th firm
nv stm cti vi tie ly st om sa ti ch de la se ro fa ct nc lu
sto ri ce rfo iti ys tor cl ie fe ba th ra ofi ta il iti fi rm ic im cte
 th fi rm si ss ac tiv ti nc lu th er th sti tuti iti tra stm ba se vi ce
tme ki se rv ic de fi un le lu th thi ti rw ri te
 th se li gr ec ri tie nd riti th ly st ns ib fo th rt mi ch pe tu sk mb th yst
 se ld th mm th sd ati te ru le th ro ib se rc ly st
fro tra cu iti es co er ri ci fie tim ri ds nd fte th bl ic tio ea ch rt
 ar ri gto ea ch ss ci te ful l- se rv ic fin ia se rv ic fi rm th ffe rs va ie ty se rv ic ro ct cl ie ts
tor ul ss th rri gt ar ch ek ng il ek stm nk ng oth bu el tio hi th th
co ie nd ts es rc ra ar ri gto se rc ce stm -r el te co en tio fro thi
co th th pa th xp ct thi th thr mo th
barrington research associ inc finra-regist broker/deal clear wedbush secur fulli
disclos basi conveni client offer sever way client facilit payment
trade barrington research order may place trade desk
trader michael hutchison head trader christoph pari email address
instant messeng address brrrmh
trade broker trade may also stepped-in barrington research trade execut broker
commiss share arrang barrington commiss share agreement numer broker wall
street complet list commiss share program barrington research particip pleas contact
salesperson trade desk
follow list provid barrington research trade alloc settlement id wedbush dtc code
question trade set account relat inform pleas call trade depart
inform contain herein obtain sourc believ reliabl guarante accuraci complet
opinion estim reflect best judgment report date subject chang without notic report intend inform
purpos constitut offer solicit buy sell secur barrington research associ inc affili offic
analyst employe may time time posit secur refer herein barrington research associ inc may act
princip agent buyer seller purchas sale secur mention report barrington research associ
inc may provid may seek provid invest bank servic compani mention report report may
reproduc form without prior written consent barrington research associ inc right reserv member finra/sipc
